GB Patent

GB2450691A — One-pot preparation of oxycodone from thebaine

Assigned to Xellia Pharmaceuticals ApS · Expires 2009-01-07 · 17y expired

What this patent protects

A process for the large scale preparation of oxycodone from thebaine which comprises: <SL> <LI>(i) oxidation of thebaine to 14-hydroxycodeinone with a peroxide; and <LI>(ii) reduction of 14-hydroxycodeinone with hydrogen, characterised in that: <LI>(iii) t…

USPTO Abstract

A process for the large scale preparation of oxycodone from thebaine which comprises: <SL> <LI>(i) oxidation of thebaine to 14-hydroxycodeinone with a peroxide; and <LI>(ii) reduction of 14-hydroxycodeinone with hydrogen, characterised in that: <LI>(iii) the oxidation reaction is carried out on more than 50g of thebaine, and <LI>(iv) both the oxidation and reduction reactions are carried out in acetic acid or propionic acid; and <LI>(v) both the oxidation and reduction reactions are carried out in the same vessel without isolation of the 14-hydroxycodeinone; and <LI>(vi) the oxidation reaction is performed at a temperature below 35{C. </SL> Glacial acetic acid and hydrogen peroxide are preferably used in the oxidation reaction. Preferred catalysts for the hydrogenation include palladium on carbon (Pd/C), platinum dioxide and Raney nickel.

Drugs covered by this patent

Patent Metadata

Patent number
GB2450691A
Jurisdiction
GB
Classification
Expires
2009-01-07
Drug substance claim
No
Drug product claim
No
Assignee
Xellia Pharmaceuticals ApS
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.